Source: Richard Moorhead
The nation of Slovenia has suspended use of the Johnson & Johnson coronavirus vaccine, following the death of a 20-year old woman two weeks after she received the jab.
Health Minister Janez Poklukar announced use of J&J would be suspended while health authorities investigate potential connections between the use of the vaccine and the woman’s death as a result of a stroke.
Poklukar described the woman’s death as resulting from a “suspected serious adverse event” at the Ljubljana University Medical Centre. In a statement, Poklukar described such incidences as extremely rare, encouraging the Slovenian public to get other vaccines while authorities investigate any connection between the death and the Johnson & Johnson vaccine.
Use of the Johnson & Johnson vaccine has continued, even as reliable information indicates it’s more likely to have side effects on recipients than other vaccines manufactured by Pfizer and Moderna. Some individuals seeking vaccination take the Johnson vaccine because it only requires one injection, whereas other vaccines require two different injections several weeks apart.
Slovenia is one of several Central European nations to introduce vaccine passports in recent weeks, now requiring them for employees of the government. Coronavirus cases have increased in Central Europe, with citizens increasingly staging protests of vaccine mandates similar to those seen in Western Europe.
Slovenia had previously purchased 100,000 Johnson vaccines from Hungary to meet rising demand. The Astra-Zeneca vaccine had started off as the most popular in Europe, before concerns over efficacy led to the mass adoption of the American Pfizer vaccine as an alternative.